LV11689B - 4-£(2-benzothiazolyl)methylamino|-alpha-£(3,4-difluorophenoxy)methyl|-1-piperidineethanol - Google Patents

4-£(2-benzothiazolyl)methylamino|-alpha-£(3,4-difluorophenoxy)methyl|-1-piperidineethanol Download PDF

Info

Publication number
LV11689B
LV11689B LVP-96-334A LV960334A LV11689B LV 11689 B LV11689 B LV 11689B LV 960334 A LV960334 A LV 960334A LV 11689 B LV11689 B LV 11689B
Authority
LV
Latvia
Prior art keywords
formula
compound
optionally
inert solvent
reaction conditions
Prior art date
Application number
LVP-96-334A
Other languages
English (en)
Latvian (lv)
Other versions
LV11689A (lv
Inventor
Raymond Antoine Stokbroekx
Gilbert Arthur Jules Grauwels
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of LV11689A publication Critical patent/LV11689A/xx
Publication of LV11689B publication Critical patent/LV11689B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Paper (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
LVP-96-334A 1991-02-25 1996-08-13 4-£(2-benzothiazolyl)methylamino|-alpha-£(3,4-difluorophenoxy)methyl|-1-piperidineethanol LV11689B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25
PCT/EP1992/000356 WO1992014731A1 (en) 1991-02-25 1992-02-14 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL

Publications (2)

Publication Number Publication Date
LV11689A LV11689A (lv) 1997-02-20
LV11689B true LV11689B (en) 1997-08-20

Family

ID=24646210

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-96-334A LV11689B (en) 1991-02-25 1996-08-13 4-£(2-benzothiazolyl)methylamino|-alpha-£(3,4-difluorophenoxy)methyl|-1-piperidineethanol

Country Status (36)

Country Link
US (2) US5434168A (de)
EP (2) EP0573473B1 (de)
JP (1) JP2825652B2 (de)
KR (1) KR0165901B1 (de)
CN (3) CN1033454C (de)
AT (1) ATE131478T1 (de)
AU (1) AU649788B2 (de)
BG (1) BG62332B1 (de)
CA (1) CA2104000A1 (de)
CY (1) CY1924A (de)
CZ (1) CZ284705B6 (de)
DE (1) DE69206787T2 (de)
DK (1) DK0573473T3 (de)
DZ (1) DZ1560A1 (de)
EE (1) EE02983B1 (de)
ES (1) ES2083737T3 (de)
FI (1) FI933719A (de)
GR (1) GR3018692T3 (de)
HK (1) HK172296A (de)
HU (2) HUT67695A (de)
IE (1) IE69567B1 (de)
IL (3) IL100952A (de)
LV (1) LV11689B (de)
MA (1) MA22447A1 (de)
MX (1) MX9200777A (de)
NO (1) NO300591B1 (de)
NZ (2) NZ248437A (de)
PL (1) PL168791B1 (de)
RO (1) RO112959B1 (de)
RU (2) RU2094434C1 (de)
SK (1) SK278705B6 (de)
TN (1) TNSN92017A1 (de)
TW (1) TW218016B (de)
WO (1) WO1992014731A1 (de)
ZA (1) ZA921341B (de)
ZW (1) ZW1992A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (de) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
NZ295132A (en) * 1994-10-14 1998-06-26 Janssen Pharmaceutica Nv Sabeluzole aqueous suspension having ph from 8 to 10
EP0794777A1 (de) * 1994-11-24 1997-09-17 Janssen Pharmaceutica N.V. Lubeluzolhaltige intravenöse lösungen
JPH10501823A (ja) * 1995-04-10 1998-02-17 バクスター、インターナショナル、インコーポレイテッド クモ膜下出血の治療における架橋ヘモグロビンの使用
IL123083A0 (en) * 1995-10-25 1998-09-24 Janssen Pharmaceutica Nv Lubeluzole n-oxides their preparation and pharmaceutical compositions containing them
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
ATE296814T1 (de) * 1999-05-12 2005-06-15 Neurosearch As Ionenkanal modulierende mittel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
MA22447A1 (fr) 1992-10-01
LV11689A (lv) 1997-02-20
RU2094434C1 (ru) 1997-10-27
JP2825652B2 (ja) 1998-11-18
ZA921341B (en) 1993-08-24
US5434168A (en) 1995-07-18
EE02983B1 (et) 1997-04-15
RO112959B1 (ro) 1998-02-27
CN1033454C (zh) 1996-12-04
SK278705B6 (sk) 1998-01-14
PL168791B1 (pl) 1996-04-30
IL100952A0 (en) 1992-11-15
EP0501552A1 (de) 1992-09-02
HUT67695A (en) 1995-04-28
RU95112519A (ru) 1997-04-20
ATE131478T1 (de) 1995-12-15
IL100952A (en) 1995-12-31
HK172296A (en) 1996-09-20
BG98068A (bg) 1994-06-30
CN1043609C (zh) 1999-06-16
NZ241592A (en) 1994-07-26
BG62332B1 (bg) 1999-08-31
CA2104000A1 (en) 1992-08-26
HU211560A9 (en) 1995-12-28
DZ1560A1 (fr) 2002-02-17
IE69567B1 (en) 1996-10-02
AU1208592A (en) 1992-09-15
NO933010D0 (no) 1993-08-24
IL113837A (en) 1996-05-14
FI933719A0 (fi) 1993-08-24
DE69206787D1 (de) 1996-01-25
IE920575A1 (en) 1992-08-26
DE69206787T2 (de) 1996-06-05
EP0573473A1 (de) 1993-12-15
NO300591B1 (no) 1997-06-23
IL113837A0 (en) 1995-08-31
TW218016B (de) 1993-12-21
MX9200777A (es) 1992-08-01
ZW1992A1 (en) 1993-09-22
CN1064865A (zh) 1992-09-30
CN1113437A (zh) 1995-12-20
RU2106348C1 (ru) 1998-03-10
KR0165901B1 (en) 1999-01-15
EP0573473B1 (de) 1995-12-13
CS51292A3 (en) 1992-09-16
GR3018692T3 (en) 1996-04-30
JPH06505012A (ja) 1994-06-09
CY1924A (en) 1997-03-07
FI933719A (fi) 1993-08-24
CN1117048A (zh) 1996-02-21
US5675027A (en) 1997-10-07
WO1992014731A1 (en) 1992-09-03
NZ248437A (en) 1994-07-26
NO933010L (no) 1993-08-24
DK0573473T3 (da) 1996-01-29
CZ284705B6 (cs) 1999-02-17
HU9302395D0 (en) 1993-11-29
TNSN92017A1 (fr) 1993-06-08
AU649788B2 (en) 1994-06-02
ES2083737T3 (es) 1996-04-16

Similar Documents

Publication Publication Date Title
EP2049518B1 (de) Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
US9815832B2 (en) Azabenzimidazole compounds
US11939292B1 (en) Aza-substituted psilocin analogs and methods of synthesizing the same
EP0232937B1 (de) N-Heterozyklische-4-piperidinamine enthaltende anti-histaminische Zusammensetzungen
US11629136B1 (en) Substituted pyridine derivatives as SARM1 inhibitors
JPS61137884A (ja) ベンズオキサゾール‐及びベンゾチアゾールアミン誘導体
US11932617B2 (en) Compound for use in retinal diseases
LV11689B (en) 4-£(2-benzothiazolyl)methylamino|-alpha-£(3,4-difluorophenoxy)methyl|-1-piperidineethanol
CZ580390A3 (en) 6-ARYL-5,6-DIHYDRO-IMIDAZO£2,1-b|THIAZOLE DERIVATIVES, PROCESS OF THEIR PREPARATION, INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
WO2023219789A1 (en) Novel psilocin prodrug compounds and methods of synthesizing the same
US5530011A (en) 4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
US12064415B2 (en) Psilocin prodrug compounds and methods of synthesizing the same
US20240217949A1 (en) Compound for use in retinal diseases
CN109280028B (zh) 喹啉类化合物及其在dpp-4酶抑制剂的应用
KR20240046553A (ko) Sting 길항제로서의 소분자 우레아 유도체
TW202310830A (zh) 用於治療疾病之β-內醯胺衍生物